WIN 55,212–2 selectively induces apoptosis in multiple myeloma cell lines via the CB2 receptor, activating caspases and altering Bcl-2 family protein expression, while normal cells remain unaffected. The gene discussed is BCL2; the disease is plasma cell myeloma.